Incidence of cardiovascular events among tildrakizumab‐treated patients with moderate‐to‐severe plaque psoriasis: pooled data from three large randomised clinical trials.
Saved in:
| Title: | Incidence of cardiovascular events among tildrakizumab‐treated patients with moderate‐to‐severe plaque psoriasis: pooled data from three large randomised clinical trials. |
|---|---|
| Authors: | Bissonnette, R.1 (AUTHOR) rbissonnette@innovaderm.ca, Fernández‐Peñas, P.2,3 (AUTHOR), Puig, L.4 (AUTHOR), Mendelsohn, A.M.5 (AUTHOR), Rozzo, S.J.5 (AUTHOR), Menter, A.6 (AUTHOR) |
| Source: | Journal of the European Academy of Dermatology & Venereology. Jan2020, Vol. 34 Issue 1, pe21-e24. 4p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
